Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 1/2004

01-07-2004

Response to Cyclosporine Therapy in Patients with Myelodysplastic Syndrome: A Clinical Study of 12 Cases and Literature Review

Authors: Masao Ogata, Eiichi Ohtsuka, Tomoyuki Imamura, Junji Ikewaki, Yuko Ogata, Kazuhiro Kohno, Toshiyuki Nakayama, Keiji Ono, Yoshio Saburi, Hiroshi Kikuchi, Masaru Nasu

Published in: International Journal of Hematology | Issue 1/2004

Login to get access
Metadata
Title
Response to Cyclosporine Therapy in Patients with Myelodysplastic Syndrome: A Clinical Study of 12 Cases and Literature Review
Authors
Masao Ogata
Eiichi Ohtsuka
Tomoyuki Imamura
Junji Ikewaki
Yuko Ogata
Kazuhiro Kohno
Toshiyuki Nakayama
Keiji Ono
Yoshio Saburi
Hiroshi Kikuchi
Masaru Nasu
Publication date
01-07-2004
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.04051

Other articles of this Issue 1/2004

International Journal of Hematology 1/2004 Go to the issue

Case Report

Exaggerated Cutaneous Response to Mosquito Bites in a Patient with Chronic Lymphocytic Leukemia

Case Report

Successful Treatment of Idiopathic Hypereosinophilic Syndrome with Imatinib Mesylate: A Case Report

OriginalPaper

The Effects of Desflurane on Human Platelet Aggregation In Vitro

Letter to the Editor

False-Positive Plasma (1↙3)-β-D-Glucan Test following Immunoglobulin Product Replacement in an Adult Bone Marrow Recipient

OriginalPaper

Angiopoietin-Related/Angiopoietin-Like Proteins Regulate Angiogenesis

OriginalPaper

Clinical Relevance of Survivin as a Biomarker in Neoplasms, Especially in Adult T-Cell Leukemias and Acute Leukemias
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits